119 related articles for article (PubMed ID: 7911526)
21. Antibody spectrum against the viral transactivator protein in patients with human immunodeficiency virus type 1 infection and Kaposi's sarcoma.
Demirhan I; Chandra A; Mueller F; Mueller H; Biberfeld P; Hasselmayer O; Chandra P
J Hum Virol; 2000; 3(3):137-43. PubMed ID: 10881993
[TBL] [Abstract][Full Text] [Related]
22. Human immunodeficiency virus-related microvasculopathy and Kaposi's sarcoma: a case-control study.
Baumann S; Geier SA; Thoma-Gerber E; Noehl MA; Klauss V; Goebel FD
Ger J Ophthalmol; 1995 Jul; 4(4):239-45. PubMed ID: 7492937
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
Ziegler JL; Katongole-Mbidde E
Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
[TBL] [Abstract][Full Text] [Related]
24. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma.
Miles SA; Testa M; Huang J; Wade M; Carden J; Scadden DT
J Interferon Cytokine Res; 2002 Nov; 22(11):1143-8. PubMed ID: 12513914
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
26. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma.
Pluda JM; Shay LE; Foli A; Tannenbaum S; Cohen PJ; Goldspiel BR; Adamo D; Cooper MR; Broder S; Yarchoan R
J Natl Cancer Inst; 1993 Oct; 85(19):1585-92. PubMed ID: 7692072
[TBL] [Abstract][Full Text] [Related]
27. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not.
Quinlivan EB; Zhang C; Stewart PW; Komoltri C; Davis MG; Wehbie RS
J Infect Dis; 2002 Jun; 185(12):1736-44. PubMed ID: 12085319
[TBL] [Abstract][Full Text] [Related]
28. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
29. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
30. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.
Whitby D; Howard MR; Tenant-Flowers M; Brink NS; Copas A; Boshoff C; Hatzioannou T; Suggett FE; Aldam DM; Denton AS
Lancet; 1995 Sep; 346(8978):799-802. PubMed ID: 7674745
[TBL] [Abstract][Full Text] [Related]
31. Clinical and histopathological aspects of Kaposi's sarcoma in Africa: relationship with HIV serology.
Lesbordes JL; Martin PM; Ravisse P; Georges-Courbot MC; Georges AJ
Ann Inst Pasteur Virol; 1988; 139(2):197-203. PubMed ID: 2905140
[TBL] [Abstract][Full Text] [Related]
32. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
33. Differences in androgens of HIV positive patients with and without Kaposi sarcoma.
Christeff N; Winter C; Gharakhanian S; Thobie N; Wirbel E; Costagliola D; Nunez EA; Rozenbaum W
J Clin Pathol; 1995 Jun; 48(6):513-8. PubMed ID: 7665693
[TBL] [Abstract][Full Text] [Related]
34. In vitro modulation of human endothelial cell growth by Kaposi's sarcoma sera.
Ferraro G; Meroni PL; Del Papa N; Barcellini W; Orietta Borghi M; Lazzarin A; Moroni M; Zanussi C
J Acquir Immune Defic Syndr (1988); 1990; 3(7):677-82. PubMed ID: 2352120
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
36. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
37. CD8(+)CD28(-) T lymphocytes from HIV-1-infected patients secrete factors that induce endothelial cell proliferation and acquisition of Kaposi's sarcoma cell features.
Alessandri G; Fiorentini S; Licenziati S; Bonafede M; Monini P; Ensoli B; Caruso A
J Interferon Cytokine Res; 2003 Sep; 23(9):523-31. PubMed ID: 14565861
[TBL] [Abstract][Full Text] [Related]
38. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma in Nigeria.
Onunu AN; Okoduwa C; Eze EU; Adeyekun AA; Kubeyinje EP; Schwartz RA
Int J Dermatol; 2007 Mar; 46(3):264-7. PubMed ID: 17343581
[TBL] [Abstract][Full Text] [Related]
40. Systemic hyperthermia in the treatment of HIV-related disseminated Kaposi's sarcoma. Long-term follow-up of patients treated with low-flow extracorporeal perfusion hyperthermia.
Alonso K; Pontiggia P; Sabato A; Calvi G; Curto FC; de Bartolomei E; Nardi C; Cereda P
Am J Clin Oncol; 1994 Aug; 17(4):353-9. PubMed ID: 7914057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
